Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
MMWR Morb Mortal Wkly Rep ; 72(46): 1269-1274, 2023 Nov 17.
Article in English | MEDLINE | ID: mdl-37971936

ABSTRACT

Introduction: Congenital syphilis cases in the United States increased 755% during 2012-2021. Syphilis during pregnancy can lead to stillbirth, miscarriage, infant death, and maternal and infant morbidity; these outcomes can be prevented through appropriate screening and treatment. Methods: A cascading framework was used to identify and classify missed opportunities to prevent congenital syphilis among cases reported to CDC in 2022 through the National Notifiable Diseases Surveillance System. Data on testing and treatment during pregnancy and clinical manifestations present in the newborn were used to identify missed opportunities to prevent congenital syphilis. Results: In 2022, a total of 3,761 cases of congenital syphilis in the United States were reported to CDC, including 231 (6%) stillbirths and 51 (1%) infant deaths. Lack of timely testing and adequate treatment during pregnancy contributed to 88% of cases of congenital syphilis. Testing and treatment gaps were present in the majority of cases across all races, ethnicities, and U.S. Census Bureau regions. Conclusions and implications for public health practice: Addressing missed opportunities for prevention, primarily timely testing and appropriate treatment of syphilis during pregnancy, is important for reversing congenital syphilis trends in the United States. Implementing tailored strategies addressing missed opportunities at the local and national levels could substantially reduce congenital syphilis.


Subject(s)
Pregnancy Complications, Infectious , Syphilis, Congenital , Syphilis , Infant , Infant, Newborn , Pregnancy , Female , Humans , United States/epidemiology , Syphilis, Congenital/epidemiology , Syphilis, Congenital/prevention & control , Syphilis/diagnosis , Syphilis/epidemiology , Syphilis/prevention & control , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & control , Population Surveillance , Stillbirth , Vital Signs
3.
Sex Transm Dis ; 45(5): 287-293, 2018 05.
Article in English | MEDLINE | ID: mdl-29465688

ABSTRACT

We undertook a systematic review to examine rectal Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) infections in women and men who have sex with men (MSM). English-language publications measuring rectal Ct or Ng prevalence using nucleic acid amplification tests were eligible. Searching multiple electronic databases, we identified 115 eligible reports published between January 2000 and November 2016. Overall, the prevalence of rectal Ct (9%) was higher than that of rectal Ng (4.7%). Rectal Ct prevalence was similar in MSM (9%) and women (9.2%), whereas rectal Ng prevalence was higher in MSM (6.1%) than in women (1.7%). Generally, rectal Ct prevalence was similar in sexually transmitted disease clinics (9.1%) and nonsexual health clinics (8.6%), whereas rectal Ng prevalence was somewhat lower in sexually transmitted disease clinics (4.5%) than in nonsexual health clinics (6%). These infections seem to be relatively common across a range of populations and clinical settings, highlighting the need for additional research on these preventable, treatable conditions.


Subject(s)
Chlamydia Infections/epidemiology , Gonorrhea/epidemiology , Rectal Diseases/epidemiology , Rectum/microbiology , Chlamydia trachomatis/genetics , Female , Homosexuality, Male , Humans , Male , Neisseria gonorrhoeae/genetics , Nucleic Acid Amplification Techniques , Prevalence , Rectal Diseases/microbiology , Sexual and Gender Minorities
4.
Sex Transm Dis ; 45(2): 81-86, 2018 02.
Article in English | MEDLINE | ID: mdl-28876293

ABSTRACT

BACKGROUND: The number of categorical sexually transmitted disease (STD) clinics is declining in the United States. Federally qualified health centers (FQHCs) have the potential to supplement the needed sexually transmitted infection (STI) services. In this study, we describe the spatial distribution of FQHC sites and determine if reported county-level nonviral STI morbidity were associated with having FQHC(s) using spatial regression techniques. METHODS: We extracted map data from the Health Resources and Services Administration data warehouse on FQHCs (ie, geocoded health care service delivery [HCSD] sites) and extracted county-level data on the reported rates of chlamydia, gonorrhea and, primary and secondary (P&S) syphilis (2008-2012) from surveillance data. A 3-equation seemingly unrelated regression estimation procedure (with a spatial regression specification that controlled for county-level multiyear (2008-2012) demographic and socioeconomic factors) was used to determine the association between reported county-level STI morbidity and HCSD sites. RESULTS: Counties with HCSD sites had higher STI, poverty, unemployment, and violent crime rates than counties with no HCSD sites (P < 0.05). The number of HCSD sites was associated (P < 0.01) with increases in the temporally smoothed rates of chlamydia, gonorrhea, and P&S syphilis, but there was no significant association between the number of HCSD per 100,000 population and reported STI rates. CONCLUSIONS: There is a positive association between STI morbidity and the number of HCSD sites; however, this association does not exist when adjusting by population size. Further work may determine the extent to which HCSD sites can meet unmet needs for safety net STI services.


Subject(s)
Chlamydia Infections/epidemiology , Gonorrhea/epidemiology , Sexually Transmitted Diseases/epidemiology , Spatial Regression , Syphilis/epidemiology , Adult , Cross-Sectional Studies , Demography , Female , Health Facilities , Humans , Male , Morbidity , Poverty , Socioeconomic Factors , United States/epidemiology , Young Adult
5.
Public Health Rep ; 130(6): 602-9, 2015.
Article in English | MEDLINE | ID: mdl-26556931

ABSTRACT

The Patient Protection and Affordable Care Act is expected to reduce the number of uninsured people in the United States during the next eight years, but more than 10% are expected to remain uninsured. Uninsured people are one of the main populations using publicly funded safety net sexually transmitted disease (STD) prevention services. Estimating the proportion of the uninsured population expected to need STD services could help identify the potential demand for safety net STD services and improve program planning. In 2013, an estimated 8.27 million people met the criteria for being in need of STD services. In 2023, 4.70 million uninsured people are expected to meet the criteria for being in need of STD services. As an example, the cost in 2014 U.S. dollars of providing chlamydia screening to these people was an estimated $271.1 million in 2013 and is estimated to be $153.8 million in 2023. A substantial need will continue to exist for safety net STD prevention services in coming years.


Subject(s)
Safety-net Providers/economics , Sexually Transmitted Diseases/prevention & control , Adolescent , Adult , Female , Humans , Male , Medically Uninsured , United States
6.
Am J Public Health ; 105(8): e126-33, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26066961

ABSTRACT

OBJECTIVES: We examined Hispanic men's recent risky and protective sexual behaviors with female partners by acculturation. METHODS: Using the 2006-2010 National Survey of Family Growth, we performed bivariate analyses to compare acculturation groups (Hispanic Spanish-speaking immigrants, Hispanic English-speaking immigrants, Hispanic US natives, and non-Hispanic White men) by demographics and recent sexual behaviors with women. Multivariable logistic regression models for sexual behaviors by acculturation group were adjusted for demographics. RESULTS: Compared with Hispanic Spanish-speaking immigrants, non-Hispanic White men were less likely to report exchange of money or drugs for sex (adjusted odds ratio [AOR] = 0.3; 95% confidence interval [CI] = 0.1, 0.9), but were also less likely to report condom use at last vaginal (AOR = 0.6; 95% CI = 0.4, 0.8) and anal sex (AOR = 0.4; 95% CI = 0.3, 0.7). Hispanic US natives were less likely to report condom use at last vaginal sex than were Spanish-speaking immigrants (AOR = 0.6; 95% CI = 0.4, 0.8). English- and Spanish-speaking immigrants did not differ in risky or protective sexual behaviors. CONCLUSIONS: Our findings suggest that targeted interventions focusing on unique sexual risks and sociodemographic differences by acculturation level, particularly nativity, may be helpful for preventing sexually transmitted infections.


Subject(s)
Acculturation , Hispanic or Latino/psychology , Sexual Behavior/ethnology , Adolescent , Adult , Condoms/statistics & numerical data , Emigrants and Immigrants/psychology , Emigrants and Immigrants/statistics & numerical data , Female , Hispanic or Latino/ethnology , Hispanic or Latino/statistics & numerical data , Humans , Male , Safe Sex/ethnology , Safe Sex/psychology , Safe Sex/statistics & numerical data , Sexual Behavior/psychology , Sexual Behavior/statistics & numerical data , United States/epidemiology , Unsafe Sex/ethnology , Unsafe Sex/psychology , Unsafe Sex/statistics & numerical data , White People/ethnology , White People/psychology , White People/statistics & numerical data , Young Adult
7.
Sex Transm Dis ; 41(9): 538-44, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25118966

ABSTRACT

The Affordable Care Act of 2010 (ACA) contains a provision requiring private insurers issuing or renewing plans on or after September 23, 2010, to provide, without cost sharing, preventive services recommended by US Preventive Services Task Force (grades A and B), among other recommending bodies. As a grade A recommendation, chlamydia screening for sexually active young women 24 years and younger and older women at risk for chlamydia falls under this requirement. This article examines the potential effect on chlamydia screening among this population across private and public health plans and identifies lingering barriers not addressed by this legislation. Examination of the impact on women with private insurance touches upon the distinction between coverage under grandfathered plans, where the requirement does not apply, and nongrandfathered plans, where the requirement does apply. Acquisition of private health insurance through health insurance Marketplaces is also discussed. For public health plans, coverage of preventive services without cost sharing differs for individuals enrolled in standard Medicaid, covered under the Medicaid expansion included in the ACA, or those enrolled under the Children's Health Insurance Program or who fall under Early, Periodic, Screening, Diagnosis and Treatment criteria. The discussion of lingering barriers not addressed by the ACA includes the uninsured, physician reimbursement, cost sharing, confidentiality, low rates of appropriate sexual history taking by providers, and disclosures of sensitive information. In addition, the role of safety net programs that provide health care to individuals regardless of ability to pay is examined in light of the expectation that they also remain a payer of last resort.


Subject(s)
Chlamydia Infections/diagnosis , Insurance Coverage , Insurance, Health , Mass Screening/economics , Mass Screening/legislation & jurisprudence , Patient Protection and Affordable Care Act , Sexual Behavior , Adolescent , Adult , Chlamydia Infections/epidemiology , Chlamydia Infections/prevention & control , Female , Health Services Accessibility , Humans , Mass Screening/methods , Medical History Taking , Preventive Health Services/economics , Preventive Health Services/legislation & jurisprudence , United States/epidemiology
9.
AIDS Educ Prev ; 21(5 Suppl): 7-18, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19824831

ABSTRACT

In April 2008, the U.S. Centers for Disease Control and Prevention (CDC) hosted a national consultation meeting of academic researchers, public health officials, service providers, and community leaders to examine the HIV/AIDS epidemic and prevention needs of Hispanics/Latinos in the United States and its territories. The consultation engaged key stakeholders to review available information on HIV-related behavioral research and prevention efforts, describe gaps in current HIV prevention programs and research on Hispanics/Latinos, and identify community and societal-level factors that can increase vulnerability of Hispanics/Latinos for acquiring or transmitting HIV infection. Recommendations were also made to CDC for future collaboration with the Hispanic/Latino community in areas of HIV prevention research and prevention programs. This article summarizes participants' recommendations for HIV prevention research, program and capacity building, policy and planning, and partnerships and communication. These recommendations will be used by CDC to inform the development of a National Plan of Action for HIV/AIDS prevention among Hispanics/Latinos, and can provide a framework for use by other federal and non-federal agencies, academic researchers, community-based organizations, and policymakers as they seek to curtail the HIV epidemic among Hispanics/Latinos.


Subject(s)
Centers for Disease Control and Prevention, U.S. , Disease Outbreaks/prevention & control , HIV Infections , Hispanic or Latino , Community-Institutional Relations , Culture , Guidelines as Topic , HIV Infections/ethnology , HIV Infections/prevention & control , Humans , Sexual Behavior/ethnology , United States
11.
PLoS One ; 2(6): e550, 2007 Jun 20.
Article in English | MEDLINE | ID: mdl-17579722

ABSTRACT

The need for a new surveillance approach to understand the clinical outcomes and behaviors of people in care for HIV evolved from the new challenges for monitoring clinical outcomes in the HAART era, the impact of the epidemic on an increasing number of areas in the US, and the need for representative data to describe the epidemic and related resource utilization and needs. The Institute of Medicine recommended that the Centers for Disease Control and Prevention and the Heath Resources and Services Administration coordinate efforts to survey a random sample of HIV-infected persons in care, in order to more accurately measure the need for prevention and care services. The Medical Monitoring Project (MMP) was created to meet these needs. This manuscript describes the evolution and design of MMP, a new nationally representative clinical outcomes and behavioral surveillance system, and describes how MMP data will be used locally and nationally to identify care and treatment utilization needs, and to plan for prevention interventions and services.


Subject(s)
HIV Infections/prevention & control , HIV/pathogenicity , Health Behavior , Population Surveillance , Preventive Health Services/statistics & numerical data , HIV Infections/epidemiology , HIV Infections/transmission , Humans , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...